Bullfrog AI Holdings Inc. Insider Trading

BFRG

⊜ Compare

Last 12 months

Insiders bought 72K on the open market and sold nothing.

Net open-market

+72K

2 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

Sep 2026

Sep 22, 2026

Get an email when BFRG's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 22	Joshua Blacher Chief Financial Officer	Bought	50,000	$0.53	27K	333%	Form 4
Sep 22	Vininder Singh Chief Executive Officer	Bought	75,000	$0.60	45K	3.2%	Form 4
Jul 7, 2025	Vininder Singh Chief Executive Officer	Sold10b5-1 plan	29,002	$1.50	44K	1.2%	Form 4
Jul 1, 2025 – Jul 3, 2025	Vininder Singh Chief Executive Officer	Sold10b5-1 plan 3 parts	20,998	$1.57 average	33K	0.9%	Form 4
Apr 4, 2025	Vininder Singh Chief Executive Officer	Sold10b5-1 plan	5,895	$1.30	8K	0.3%	Form 4
Apr 1, 2025 – Apr 3, 2025	Vininder Singh Chief Executive Officer	Sold10b5-1 plan 3 parts	44,105	$1.51 average	67K	1.8%	Form 4

Sep 22
Joshua Blacher
Chief Financial Officer · bought 50,000 at $0.53
27K
333% of stake
Sep 22
Vininder Singh
Chief Executive Officer · bought 75,000 at $0.60
45K
3.2% of stake
Jul 7, 202510b5-1 plan
Vininder Singh
Chief Executive Officer · sold 29,002 at $1.50
44K
1.2% of stake
Jul 1, 2025 – Jul 3, 202510b5-1 plan
Vininder Singh
Chief Executive Officer · sold 20,998 at avg $1.57
33K
0.9% of stake
Apr 4, 202510b5-1 plan
Vininder Singh
Chief Executive Officer · sold 5,895 at $1.30
8K
0.3% of stake
Apr 1, 2025 – Apr 3, 202510b5-1 plan
Vininder Singh
Chief Executive Officer · sold 44,105 at avg $1.51
67K
1.8% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BFRG, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BFRG

CompareIntrinsic value

HINDVyome Holdings, Inc

$1.74-1.92%20

SERSerina Therapeutics Inc.

$1.69-7.65%40

IBIOiBio, Inc.

$0.80-2.44%10

AXIMAxim Biotechnologies Inc.

$0.00+6.67%0

ATNMActinium Pharmaceuticals Inc.

$1.41+0.71%30

IXHLIncannex Healthcare Inc.

$2.49-0.60%10

BNTCBenitec Biopharma Inc.

$9.28+10.48%10

PLPLPlandai Biotechnology Inc.

$0.00+0.00%30

Spot a number that looks wrong? Check it in BFRG's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BFRG

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.